All In MedTech

Device Trial Radar · NCT04743635

CONtrolled Focal Fibrous Band Release Method Study

Last checked: Nov 20, 2026Latest source record: Jun 6, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

74

Actual

Start

Jan 7, 2021

Primary completion

Jun 14, 2021

Study completion Mar 4, 2022

Sponsor

Lead sponsor
Revelle Aesthetics, IncNot on our public-company list
Sponsor type
Industry
First posted
Feb 8, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Female only, from 21 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Study to evaluate the safety and effectiveness of the Avéli medical device to reduce the appearance of cellulite.

Conditions

  • Cellulite

Interventions

  • Avéli deviceDevice

    Minimally invasive single procedure with the Avéli device for reduction in the appearance of cellulite in the thighs and buttocks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Mean Change From Baseline to 3 Months in Cellulite Severity Scale (CSS) Score for ParticipantsTime frame: 3 months

Locations

9 sites in 2 countries. Site status is shown where the registry gives one.

  • Clinical Site #3

    Los Angeles, California

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.